Table 1. Demographic and clinical data on epilepsy, seizure frequency, and the perceived needs of 114 PWE in the pandemic period.
| n, %, or mean±SD | |
|---|---|
| Age (years) | 45.8 (±16.2) |
| Educational level (years) | 5.9 (±4.0) |
| Sex-female | 56 (49.1%) |
| Age at epilepsy onset (years) | 23 (±18.8) |
| Seizure frequency | |
| ≥1 seizure/month | 39 (34.2%) |
| 1-11 seizures/last year | 31 (27.2%) |
| No seizures in the last year | 44 (38.6%) |
| Number of AEDs taken: one | 70 (61.4%) |
| Depression in the period before the pandemic | 30 (26.3%) |
| Epilepsy syndrome | |
| Genetic | 6 (5.3%) |
| Structural | 79 (69.3%) |
| Unknown etiology | 29 (25.4%) |
| Subjective perception in the pandemic | |
| Seizure frequency | |
| Unaltered | 99 (86.8%) |
| Increase | 11 (9.6%) |
| Decrease | 4 (3.5%) |
| Difficulty in obtaining AEDs | 47 (41.2%) |
| Difficulty in contacting health professionals | 34 (29.8%) |
| Special needs in the period | |
| Medical support and access to AEDs | 56 (49.1%) |
| Psychological support | 25 (21.9%) |
| Economic, financial, and dietary problems | 20 (17.5%) |
| Trusted information about COVID-19 | 15 (13.2%) |
COVID-19: coronavirus disease 2019; PWE: people with epilepsy; AED: antiepileptic drugs, SD: standard deviation.